Stay updated on Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.3, replacing Revision: v3.5.2, indicating a minor backend/content update without altering the study details.
    Difference
    0.1%
    Check dated 2026-04-30T18:23:56.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2; no visible changes to page content or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-04-16T11:00:44.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T18:00:03.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3; no substantive content changes to the study details are evident.
    Difference
    0.1%
    Check dated 2026-03-11T17:52:27.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    No significant changes detected on the Study Details page. The content and layout continue to present the trial design, eligibility, outcomes, and locations as before.
    Difference
    0.1%
    Check dated 2026-02-18T07:21:25.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Minor site maintenance updates were made: Revision: v3.4.2 was added and Revision: v3.4.1 was removed, along with a government operating status notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T09:17:16.000Z thumbnail image

Stay in the know with updates to Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page.